Structure

Physi-Chem Properties

Molecular Weight:  378.15
Volume:  392.361
LogP:  5.098
LogD:  3.045
LogS:  -4.097
# Rotatable Bonds:  3
TPSA:  76.74
# H-Bond Aceptor:  5
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.554
Synthetic Accessibility Score:  4.062
Fsp3:  0.304
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.795
MDCK Permeability:  1.6626556316623464e-05
Pgp-inhibitor:  0.432
Pgp-substrate:  0.007
Human Intestinal Absorption (HIA):  0.024
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.184

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.013
Plasma Protein Binding (PPB):  74.43445587158203%
Volume Distribution (VD):  1.224
Pgp-substrate:  12.930477142333984%

ADMET: Metabolism

CYP1A2-inhibitor:  0.919
CYP1A2-substrate:  0.475
CYP2C19-inhibitor:  0.647
CYP2C19-substrate:  0.291
CYP2C9-inhibitor:  0.643
CYP2C9-substrate:  0.862
CYP2D6-inhibitor:  0.628
CYP2D6-substrate:  0.206
CYP3A4-inhibitor:  0.265
CYP3A4-substrate:  0.102

ADMET: Excretion

Clearance (CL):  1.973
Half-life (T1/2):  0.211

ADMET: Toxicity

hERG Blockers:  0.007
Human Hepatotoxicity (H-HT):  0.952
Drug-inuced Liver Injury (DILI):  0.913
AMES Toxicity:  0.213
Rat Oral Acute Toxicity:  0.047
Maximum Recommended Daily Dose:  0.242
Skin Sensitization:  0.835
Carcinogencity:  0.891
Eye Corrosion:  0.003
Eye Irritation:  0.017
Respiratory Toxicity:  0.269

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474290

Natural Product ID:  NPC474290
Common Name*:   Globulixanthone B
IUPAC Name:   6,11-dihydroxy-3-methyl-3-(4-methylpent-3-enyl)pyrano[3,2-a]xanthen-12-one
Synonyms:   globulixanthone B
Standard InCHIKey:  DZEKDJJYJJYEFB-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C23H22O5/c1-13(2)6-5-10-23(3)11-9-14-18(28-23)12-16(25)22-19(14)21(26)20-15(24)7-4-8-17(20)27-22/h4,6-9,11-12,24-25H,5,10H2,1-3H3
SMILES:  CC(=CCCC1(C=CC2=C(O1)C=C(C3=C2C(=O)C4=C(C=CC=C4O3)O)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL464752
PubChem CID:   10452251
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones
                • [CHEMONTID:0003521] Pyranoxanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8408 Symphonia globulifera Species Clusiaceae Eukaryota n.a. Tanzania n.a. PMID[11430019]
NPO8408 Symphonia globulifera Species Clusiaceae Eukaryota root bark n.a. n.a. PMID[12027753]
NPO8408 Symphonia globulifera Species Clusiaceae Eukaryota leaves n.a. n.a. PMID[12502337]
NPO8408 Symphonia globulifera Species Clusiaceae Eukaryota n.a. leaf n.a. PMID[17960072]
NPO8408 Symphonia globulifera Species Clusiaceae Eukaryota n.a. root n.a. PMID[17960072]
NPO8408 Symphonia globulifera Species Clusiaceae Eukaryota seeds n.a. n.a. PMID[26221771]
NPO8408 Symphonia globulifera Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8408 Symphonia globulifera Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8408 Symphonia globulifera Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 1.78 ug.mL-1 PMID[572725]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474290 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9803 High Similarity NPC139036
0.974 High Similarity NPC23298
0.974 High Similarity NPC189473
0.9677 High Similarity NPC472450
0.9677 High Similarity NPC239752
0.9677 High Similarity NPC275780
0.9673 High Similarity NPC200746
0.9615 High Similarity NPC37870
0.9615 High Similarity NPC472449
0.9615 High Similarity NPC39091
0.9608 High Similarity NPC476242
0.9605 High Similarity NPC274730
0.9548 High Similarity NPC25152
0.9548 High Similarity NPC229632
0.9548 High Similarity NPC329760
0.9545 High Similarity NPC471973
0.9545 High Similarity NPC204290
0.9542 High Similarity NPC300727
0.9542 High Similarity NPC241904
0.9487 High Similarity NPC152659
0.9487 High Similarity NPC236521
0.9487 High Similarity NPC207690
0.9487 High Similarity NPC248638
0.9484 High Similarity NPC61010
0.9484 High Similarity NPC167678
0.9484 High Similarity NPC29876
0.9481 High Similarity NPC100123
0.9474 High Similarity NPC89474
0.9423 High Similarity NPC83922
0.9423 High Similarity NPC472448
0.9419 High Similarity NPC228785
0.9419 High Similarity NPC14353
0.9419 High Similarity NPC56085
0.9419 High Similarity NPC474960
0.9419 High Similarity NPC320359
0.9416 High Similarity NPC136674
0.9363 High Similarity NPC220313
0.9363 High Similarity NPC475985
0.9363 High Similarity NPC186686
0.9363 High Similarity NPC146134
0.9363 High Similarity NPC303460
0.9363 High Similarity NPC306321
0.9359 High Similarity NPC259456
0.9359 High Similarity NPC278052
0.9359 High Similarity NPC40491
0.9355 High Similarity NPC280680
0.9351 High Similarity NPC472907
0.9351 High Similarity NPC191146
0.9351 High Similarity NPC68093
0.9351 High Similarity NPC142339
0.9346 High Similarity NPC472905
0.9346 High Similarity NPC176775
0.9346 High Similarity NPC47781
0.9346 High Similarity NPC22519
0.9346 High Similarity NPC160951
0.9346 High Similarity NPC255350
0.9346 High Similarity NPC69394
0.9346 High Similarity NPC145379
0.9346 High Similarity NPC274327
0.9346 High Similarity NPC183878
0.9346 High Similarity NPC231018
0.9342 High Similarity NPC202157
0.9308 High Similarity NPC477154
0.9308 High Similarity NPC6588
0.9308 High Similarity NPC117854
0.9304 High Similarity NPC224280
0.9299 High Similarity NPC474162
0.9299 High Similarity NPC474150
0.9295 High Similarity NPC476980
0.9295 High Similarity NPC45146
0.9295 High Similarity NPC80375
0.9295 High Similarity NPC235018
0.929 High Similarity NPC474681
0.929 High Similarity NPC217677
0.929 High Similarity NPC475267
0.929 High Similarity NPC472911
0.929 High Similarity NPC165977
0.929 High Similarity NPC156057
0.929 High Similarity NPC472963
0.929 High Similarity NPC469584
0.929 High Similarity NPC472913
0.929 High Similarity NPC472914
0.929 High Similarity NPC474208
0.929 High Similarity NPC236796
0.929 High Similarity NPC474836
0.929 High Similarity NPC48208
0.929 High Similarity NPC96167
0.929 High Similarity NPC245758
0.929 High Similarity NPC78225
0.929 High Similarity NPC162869
0.929 High Similarity NPC218313
0.929 High Similarity NPC222814
0.929 High Similarity NPC472910
0.9286 High Similarity NPC4455
0.9286 High Similarity NPC163780
0.9286 High Similarity NPC2476
0.9286 High Similarity NPC128863
0.9286 High Similarity NPC138360
0.9286 High Similarity NPC280339
0.9286 High Similarity NPC213622
0.9286 High Similarity NPC256612
0.9286 High Similarity NPC201136
0.9286 High Similarity NPC146165
0.9286 High Similarity NPC92659
0.9286 High Similarity NPC167815
0.9286 High Similarity NPC196439
0.9286 High Similarity NPC50715
0.9286 High Similarity NPC183597
0.9286 High Similarity NPC20830
0.9286 High Similarity NPC227325
0.9281 High Similarity NPC293183
0.9281 High Similarity NPC222830
0.9281 High Similarity NPC198826
0.9281 High Similarity NPC241498
0.9281 High Similarity NPC75069
0.9281 High Similarity NPC131624
0.9281 High Similarity NPC275722
0.9281 High Similarity NPC212678
0.9281 High Similarity NPC301323
0.9281 High Similarity NPC25270
0.9281 High Similarity NPC120163
0.9281 High Similarity NPC199100
0.9281 High Similarity NPC275836
0.9281 High Similarity NPC180234
0.9281 High Similarity NPC100887
0.9281 High Similarity NPC120537
0.9281 High Similarity NPC256283
0.9281 High Similarity NPC57030
0.9281 High Similarity NPC83508
0.9281 High Similarity NPC71334
0.9281 High Similarity NPC156222
0.9281 High Similarity NPC187498
0.9281 High Similarity NPC239128
0.9281 High Similarity NPC188203
0.9281 High Similarity NPC162313
0.9276 High Similarity NPC151473
0.9276 High Similarity NPC61620
0.925 High Similarity NPC476637
0.9245 High Similarity NPC43319
0.9245 High Similarity NPC170245
0.9241 High Similarity NPC270837
0.9241 High Similarity NPC7483
0.9241 High Similarity NPC236132
0.9236 High Similarity NPC234644
0.9236 High Similarity NPC32694
0.9236 High Similarity NPC474187
0.9231 High Similarity NPC152904
0.9231 High Similarity NPC204879
0.9231 High Similarity NPC329091
0.9231 High Similarity NPC235448
0.9226 High Similarity NPC255106
0.9226 High Similarity NPC49824
0.9226 High Similarity NPC235165
0.9226 High Similarity NPC133970
0.9226 High Similarity NPC6633
0.9226 High Similarity NPC138243
0.9226 High Similarity NPC24640
0.9226 High Similarity NPC472916
0.9226 High Similarity NPC5322
0.9226 High Similarity NPC471985
0.9226 High Similarity NPC276444
0.9221 High Similarity NPC75279
0.9221 High Similarity NPC292214
0.9221 High Similarity NPC88645
0.9221 High Similarity NPC206238
0.9221 High Similarity NPC271779
0.9221 High Similarity NPC280530
0.9221 High Similarity NPC167091
0.9221 High Similarity NPC178964
0.9221 High Similarity NPC276409
0.9221 High Similarity NPC95842
0.9221 High Similarity NPC250822
0.9216 High Similarity NPC117579
0.9216 High Similarity NPC208043
0.9216 High Similarity NPC226973
0.9216 High Similarity NPC251110
0.9211 High Similarity NPC259713
0.9211 High Similarity NPC294502
0.9211 High Similarity NPC216318
0.9211 High Similarity NPC296197
0.9211 High Similarity NPC200221
0.9211 High Similarity NPC17286
0.9193 High Similarity NPC101107
0.9187 High Similarity NPC218226
0.9187 High Similarity NPC126204
0.9187 High Similarity NPC476306
0.9182 High Similarity NPC293319
0.9182 High Similarity NPC234052
0.9182 High Similarity NPC156432
0.9182 High Similarity NPC326520
0.9177 High Similarity NPC52204
0.9177 High Similarity NPC261470
0.9177 High Similarity NPC294965
0.9177 High Similarity NPC472964
0.9172 High Similarity NPC472902
0.9172 High Similarity NPC118256
0.9172 High Similarity NPC119224
0.9172 High Similarity NPC474287
0.9172 High Similarity NPC192686
0.9172 High Similarity NPC36217

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474290 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9346 High Similarity NPD2801 Approved
0.9032 High Similarity NPD1934 Approved
0.8882 High Similarity NPD1511 Approved
0.8854 High Similarity NPD2393 Clinical (unspecified phase)
0.8766 High Similarity NPD1512 Approved
0.8712 High Similarity NPD6167 Clinical (unspecified phase)
0.8712 High Similarity NPD6168 Clinical (unspecified phase)
0.8712 High Similarity NPD6166 Phase 2
0.8625 High Similarity NPD3882 Suspended
0.858 High Similarity NPD5494 Approved
0.8571 High Similarity NPD4338 Clinical (unspecified phase)
0.8554 High Similarity NPD7054 Approved
0.8503 High Similarity NPD7472 Approved
0.8503 High Similarity NPD7074 Phase 3
0.85 High Similarity NPD1465 Phase 2
0.8494 Intermediate Similarity NPD3818 Discontinued
0.8447 Intermediate Similarity NPD3817 Phase 2
0.8395 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8364 Intermediate Similarity NPD6232 Discontinued
0.8344 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8343 Intermediate Similarity NPD6797 Phase 2
0.8333 Intermediate Similarity NPD5844 Phase 1
0.8323 Intermediate Similarity NPD3750 Approved
0.8323 Intermediate Similarity NPD7473 Discontinued
0.8313 Intermediate Similarity NPD4380 Phase 2
0.8294 Intermediate Similarity NPD7251 Discontinued
0.8246 Intermediate Similarity NPD7808 Phase 3
0.8232 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8228 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8221 Intermediate Similarity NPD5402 Approved
0.816 Intermediate Similarity NPD7819 Suspended
0.8129 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8129 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD3749 Approved
0.8084 Intermediate Similarity NPD6959 Discontinued
0.8077 Intermediate Similarity NPD1549 Phase 2
0.8067 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD7075 Discontinued
0.8 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD3748 Approved
0.8 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD1510 Phase 2
0.7974 Intermediate Similarity NPD943 Approved
0.7962 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7949 Intermediate Similarity NPD2796 Approved
0.7939 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7907 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.787 Intermediate Similarity NPD1247 Approved
0.7865 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD1613 Approved
0.7857 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD1240 Approved
0.7834 Intermediate Similarity NPD2935 Discontinued
0.7826 Intermediate Similarity NPD6799 Approved
0.7818 Intermediate Similarity NPD7411 Suspended
0.7806 Intermediate Similarity NPD447 Suspended
0.7791 Intermediate Similarity NPD5403 Approved
0.7785 Intermediate Similarity NPD2346 Discontinued
0.7778 Intermediate Similarity NPD3926 Phase 2
0.7771 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD6559 Discontinued
0.7771 Intermediate Similarity NPD6801 Discontinued
0.7758 Intermediate Similarity NPD6599 Discontinued
0.7756 Intermediate Similarity NPD1607 Approved
0.7751 Intermediate Similarity NPD6234 Discontinued
0.7746 Intermediate Similarity NPD3751 Discontinued
0.7738 Intermediate Similarity NPD7768 Phase 2
0.7722 Intermediate Similarity NPD6100 Approved
0.7722 Intermediate Similarity NPD6099 Approved
0.7719 Intermediate Similarity NPD3787 Discontinued
0.7697 Intermediate Similarity NPD3226 Approved
0.7688 Intermediate Similarity NPD2800 Approved
0.768 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD5401 Approved
0.7669 Intermediate Similarity NPD2534 Approved
0.7669 Intermediate Similarity NPD2532 Approved
0.7669 Intermediate Similarity NPD2533 Approved
0.7662 Intermediate Similarity NPD3027 Phase 3
0.7644 Intermediate Similarity NPD7228 Approved
0.7636 Intermediate Similarity NPD1653 Approved
0.763 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7598 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7581 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD37 Approved
0.7558 Intermediate Similarity NPD7199 Phase 2
0.7548 Intermediate Similarity NPD4625 Phase 3
0.7547 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD2799 Discontinued
0.7544 Intermediate Similarity NPD919 Approved
0.7531 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD4967 Phase 2
0.7529 Intermediate Similarity NPD4966 Approved
0.7529 Intermediate Similarity NPD4965 Approved
0.75 Intermediate Similarity NPD1551 Phase 2
0.75 Intermediate Similarity NPD2313 Discontinued
0.75 Intermediate Similarity NPD7390 Discontinued
0.7486 Intermediate Similarity NPD8312 Approved
0.7486 Intermediate Similarity NPD8313 Approved
0.7484 Intermediate Similarity NPD4908 Phase 1
0.7471 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD1933 Approved
0.7468 Intermediate Similarity NPD230 Phase 1
0.7455 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD2344 Approved
0.7423 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD6776 Approved
0.7394 Intermediate Similarity NPD6779 Approved
0.7394 Intermediate Similarity NPD6777 Approved
0.7394 Intermediate Similarity NPD6780 Approved
0.7394 Intermediate Similarity NPD6781 Approved
0.7394 Intermediate Similarity NPD6778 Approved
0.7394 Intermediate Similarity NPD6782 Approved
0.7389 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD7685 Pre-registration
0.7368 Intermediate Similarity NPD4288 Approved
0.7355 Intermediate Similarity NPD2798 Approved
0.7353 Intermediate Similarity NPD6844 Discontinued
0.7333 Intermediate Similarity NPD7549 Discontinued
0.7317 Intermediate Similarity NPD4628 Phase 3
0.7316 Intermediate Similarity NPD6823 Phase 2
0.729 Intermediate Similarity NPD1470 Approved
0.729 Intermediate Similarity NPD1203 Approved
0.729 Intermediate Similarity NPD2797 Approved
0.7289 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD3268 Approved
0.7278 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD3764 Approved
0.7277 Intermediate Similarity NPD7435 Discontinued
0.7273 Intermediate Similarity NPD6190 Approved
0.7273 Intermediate Similarity NPD4749 Approved
0.7273 Intermediate Similarity NPD2309 Approved
0.7268 Intermediate Similarity NPD8150 Discontinued
0.7262 Intermediate Similarity NPD920 Approved
0.7256 Intermediate Similarity NPD1243 Approved
0.7256 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD1610 Phase 2
0.7255 Intermediate Similarity NPD1201 Approved
0.7238 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD4308 Phase 3
0.7216 Intermediate Similarity NPD5711 Approved
0.7216 Intermediate Similarity NPD5710 Approved
0.7197 Intermediate Similarity NPD2861 Phase 2
0.7197 Intermediate Similarity NPD9494 Approved
0.7194 Intermediate Similarity NPD7783 Phase 2
0.7194 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD4287 Approved
0.7188 Intermediate Similarity NPD7697 Approved
0.7188 Intermediate Similarity NPD7696 Phase 3
0.7188 Intermediate Similarity NPD7698 Approved
0.7182 Intermediate Similarity NPD7240 Approved
0.7178 Intermediate Similarity NPD5408 Approved
0.7178 Intermediate Similarity NPD5406 Approved
0.7178 Intermediate Similarity NPD5404 Approved
0.7178 Intermediate Similarity NPD5405 Approved
0.7176 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7174 Intermediate Similarity NPD8434 Phase 2
0.715 Intermediate Similarity NPD7871 Phase 2
0.715 Intermediate Similarity NPD7870 Phase 2
0.7143 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD422 Phase 1
0.7128 Intermediate Similarity NPD7701 Phase 2
0.7128 Intermediate Similarity NPD4363 Phase 3
0.7128 Intermediate Similarity NPD6535 Approved
0.7128 Intermediate Similarity NPD4360 Phase 2
0.7128 Intermediate Similarity NPD6534 Approved
0.7127 Intermediate Similarity NPD5953 Discontinued
0.7126 Intermediate Similarity NPD3300 Phase 2
0.7111 Intermediate Similarity NPD7286 Phase 2
0.7105 Intermediate Similarity NPD1548 Phase 1
0.7101 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD6651 Approved
0.7097 Intermediate Similarity NPD9717 Approved
0.7092 Intermediate Similarity NPD8151 Discontinued
0.7081 Intermediate Similarity NPD4060 Phase 1
0.7079 Intermediate Similarity NPD5242 Approved
0.7056 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD7874 Approved
0.7044 Intermediate Similarity NPD6832 Phase 2
0.7041 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD2403 Approved
0.7037 Intermediate Similarity NPD5124 Phase 1
0.7037 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD7229 Phase 3
0.702 Intermediate Similarity NPD7801 Approved
0.702 Intermediate Similarity NPD6671 Approved
0.7019 Intermediate Similarity NPD6233 Phase 2
0.7016 Intermediate Similarity NPD7700 Phase 2
0.7016 Intermediate Similarity NPD7699 Phase 2
0.7012 Intermediate Similarity NPD7033 Discontinued
0.7006 Intermediate Similarity NPD3225 Approved
0.7 Intermediate Similarity NPD7095 Approved
0.6995 Remote Similarity NPD2493 Approved
0.6995 Remote Similarity NPD2494 Approved
0.6994 Remote Similarity NPD7615 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data